Robotic stereotactic ablative radiotherapy for renal cell carcinoma in patients with impaired renal function

BACKGROUND: Robotic stereotactic ablative radiotherapy (SABR) is currently under investigation as a noninvasive treatment option for patients with renal cell carcinoma (RCC). For radiation therapy of RCC, tumor motion and the need for high ablative doses while preserving the remaining renal parenchy...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Urol
Main Authors: Senger, C., Conti, A., Kluge, A., Pasemann, D., Kufeld, M., Acker, G., Lukas, M., Grün, A., Kalinauskaite, G., Budach, V., Waiser, J., Stromberger, C.
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2019
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6805546/
https://ncbi.nlm.nih.gov/pubmed/31638979
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12894-019-0531-z
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados